Amgen Inc.

Amgen Inc. is a leading biotechnology company focused on discovering, developing, and delivering innovative human therapeutics. As one of the world's largest independent biotechnology firms, Amgen plays a vital role in advancing medical research, particularly within areas of oncology, nephrology, and bone health. The company is renowned for pioneering therapies that address serious illnesses where the unmet medical needs are significant. Notable products of Amgen include biologic medications such as Enbrel, used for treating autoimmune diseases, and Neulasta, which is used to decrease the incidence of infection in patients undergoing chemotherapy. Amgen's commitment to research and development emphasizes the exploration of novel science and biotechnological advances to improve lives. Headquartered in Thousand Oaks, California, Amgen's multi-sector impact extends across healthcare innovation, patient care improvement, and global health contributions, reinforcing its position as a pivotal player in the biopharmaceutical industry.